News
SNN
27.86
+0.69%
0.19
Weekly Report: what happened at SNN last week (1005-1009)?
Weekly Report · 1d ago
Smith+Nephew Sets November 4 Date for Q3 2026 Trading Update
TipRanks · 5d ago
Bank of America Securities Sticks to Their Hold Rating for Smith & Nephew Snats (SNN)
TipRanks · 10/06 13:45
Smith & Nephew: Neutral Stance Maintained as Analyst Lowers Price Target to Reflect SANTYL Risks and Higher Discount Rates
TipRanks · 10/06 10:35
Smith & Nephew announces commercial availability of Cartiheal Agili-C in Europe
TipRanks · 10/06 09:10
Smith+ Nephew's Five-Year Data Supports European Launch Of CARTIHEAL AGILI-C Implant
NASDAQ · 10/06 08:24
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
Barchart · 10/06 03:00
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
Barchart · 10/06 03:00
Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
Barchart · 10/06 03:00
Weekly Report: what happened at SNN last week (0928-1002)?
Weekly Report · 10/05 10:22
Smith & Nephew to Fully Redeem $350m 5.150% Notes Due 2027 Ahead of Maturity
TipRanks · 10/01 10:27
Smith & Nephew Updates Share Capital and Voting Rights as of 30 September 2026
TipRanks · 10/01 10:27
Smith & Nephew removed from European Conviction List at Goldman Sachs
TipRanks · 10/01 08:40
Weekly Report: what happened at SNN last week (0921-0925)?
Weekly Report · 09/28 10:17
Bank of America Securities Sticks to Its Hold Rating for Smith & Nephew (SN)
TipRanks · 09/25 16:25
Barclays Remains a Sell on Smith & Nephew (SN)
TipRanks · 09/25 06:15
Smith & Nephew’s New Knee Registry Aims to Turn Real-World Data into Market Advantage
TipRanks · 09/24 16:31
Smith & Nephew Snats (SNN) Receives a Hold from Canaccord Genuity
TipRanks · 09/23 11:16
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
Barchart · 09/23 10:11
Smith & Nephew receives 510k clearance from FDA, completes cases with LANDMARK
TipRanks · 09/22 12:10
More
Webull provides a variety of real-time SNN stock news. You can receive the latest news about Smith & Nephew through multiple platforms. This information may help you make smarter investment decisions.
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.